The result showed that treatment with PcrV-primed WT BMDMs, but not TLR4−/− or MyD88−/− BMDMs, decreased tumor growth (Supplementary Figure 8B) and weight (Supplementary Figure 8C). This evidence concerns the gene MYD88 and neoplasm.